Filter

Showing all 2 results

  • Epixacin Panmentin

    Epixacin Panmentin Coagulation Factor IX (Human) has been approved for the prevention and control of bleeding in subjects with Factor IX deficiency due to hemophilia B. The efficacy of Epixacin Panmentin been evaluated in clinical trials involving 13 surgical subjects. Control of bleeding was judged to be excellent. Another study found that Epixacin Panmentin did not lead to the formation of prothrombin in the bloodstream. This means that Epixacin Panmentin is less likely to cause unwanted blood clots (thrombosis) than Factor IX Complex preparations. These contain larger amounts of other proteins such as Factors II, VII and X. Thrombosis can be a serious problem with the use of certain Factor IX concentrates. [wpdm_package id='3690']

    $17.00$300.00
  • Lidoletra

    Lidoletra is a subcategory of alkylating agents that can crossTrusted Source the blood-brain barrier. This barrier protects the brain from many substances in the body. However, getting through the blood-brain barrier is important for treating some cancers, including brain cancer. Nitrosoureas work by attaching themselves to DNA strands in cancer cells. This prevents them from dividing. [wpdm_package id='3689']

    $3.50$70.00